Local and Systemic Immunity against Respiratory Syncytial Virus Induced by a Novel Intranasal Vaccine. A Randomized, Double-Blind, Placebo-controlled Clinical Trial-Reference-Cited by-同舟云学术

Local and Systemic Immunity against Respiratory Syncytial Virus Induced by a Novel Intranasal Vaccine. A Randomized, Double-Blind, Placebo-controlled Clinical Trial

Published:2019-08-15 Issue:4 Volume:200 Page:481-492
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Ascough Stephanie¹²,Vlachantoni Iris²,Kalyan Mohini¹²,Haijema Bert-Jan³,Wallin-Weber Sanna³,Dijkstra-Tiekstra Margriet³,Ahmed Muhammad S.⁴,van Roosmalen Maarten³,Grimaldi Roberto³,Zhang Qibo⁴,Leenhouts Kees³,Openshaw Peter J.²,Chiu Christopher¹^ORCID

Affiliation:

1. Section of Infectious Diseases and Immunity, Department of Medicine, and

2. Section of Respiratory Infections, National Heart and Lung Institute, Imperial College London, London, United Kingdom

3. Mucosis B.V., represented by trustee Mr. Holtz, LLM, Bout Advocaten, Groningen, and Virtuvax B.V., Groningen, the Netherlands; and

4. Department of Clinical Infection, Microbiology, and Immunology, University of Liverpool, Liverpool, United Kingdom

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201810-1921OC

Reference30 articles.